Anfield Capital Management, LLC Kamada LTD Transaction History
Anfield Capital Management, LLC
- $258 Million
- Q1 2025
A detailed history of Anfield Capital Management, LLC transactions in Kamada LTD stock. As of the latest transaction made, Anfield Capital Management, LLC holds 10 shares of KMDA stock, worth $69. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$69% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KMDA
# of Institutions
40Shares Held
5.08MCall Options Held
14.3KPut Options Held
2K-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.4 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny808KShares$5.59 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA609KShares$4.21 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny448KShares$3.1 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3330KShares$2.28 Million0.19% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $310M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...